MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/0109298673262854231215065541

Медицинская библиотека · Current medicinal chemistry · 2025

N,N'-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and In Silico Studies.

de Souza Furtado Priscila, Viana Gil Mendes, de Oliveira Alana Agnes Silva Camargo, Rabelo Vitor Won-Held, Cerqueira Ingryd Wenderroschy, Paschoal Caroline Reis Santiago, da Silva Honorio Thiago, Simon Alice, Rodrigues Carlos Rangel, Abreu Paula Alvarez, Cabral Lucio Mendes, Sathler Plínio Cunha

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Thrombotic disorders are among the leading causes of morbidity and mortality worldwide. Drugs used in the prevention and treatment of atherothrombosis have pharmacokinetic limitations and adverse effects such as hemorrhagic conditions, highlighting the importance of developing more effective antiplatelet agents.

METHODS

In this work, we synthesized N,N'-disubstituted ureas 3a-3j and evaluated their antiplatelet profiles through in vitro, ex vivo, and in silico studies.

RESULTS

The synthesized derivatives exhibited a selective inhibitory profile against platelet aggregation induced by arachidonic acid (AA) in vitro, without significantly affecting other aspects of primary hemostasis and blood coagulation. The compounds that showed inhibition greater than 85% were submitted to the analysis of their potency by calculating the concentration required to inhibit 50% of platelet aggregation induced by AA (IC50). Urea derivative 3a was the most potent with IC50 of 1.45 μM. Interestingly, this derivative inhibited more than 90% of platelet aggregation induced by AA ex vivo, with a similar effect to acetylsalicylic acid. In the hemolysis assay, most of the urea derivatives presented values below 10% suggesting good hemocompatibility. Additionally, the compounds tested at 100 μM also showed no cytotoxic effects in HepG2 and Vero cells. The in silico results suggested that compound 3a may bind to the key residue of COX-1 similar to AA and known COX-1 inhibitors, and the results are also in agreement with our SAR, which suggests that the inhibition of this enzyme is the most likely mechanism of antiplatelet activity.

CONCLUSION

Therefore, these results demonstrated that N,N'-disubstituted ureas are promising candidates for the development of novel antiplatelet agents.

Для цитирования: de Souza Furtado Priscila, Viana Gil Mendes, de Oliveira Alana Agnes Silva Camargo, Rabelo Vitor Won-Held, Cerqueira Ingryd Wenderroschy, Paschoal Caroline Reis Santiago, da Silva Honorio Thiago, Simon Alice, Rodrigues Carlos Rangel, Abreu Paula Alvarez, Cabral Lucio Mendes, Sathler Plínio Cunha. N,N'-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and In Silico Studies.. Current medicinal chemistry. 2025. DOI: 10.2174/0109298673262854231215065541.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.